Chuanbing Shi

发表

Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial

Yong-bin Ding, Xiao-Feng Chen, Guo-Qun Wang, 2021, OncoTargets and therapy.